Creating a Cutting-Edge Data Hub for a Cure
Fueled by our landmark CoMMpass Study SM , the MMRF built the largest
genomics data set of any cancer in the world. We made that data publicly available
to researchers worldwide to drive data analytics, identify new targets, and answer
critical questions facing the myeloma community. (See the article on page 6 for
more information.)
Multiple myeloma is a complex, diverse disease. To achieve our vision — where we
find a cure for every patient — we need even more data. This means reaching out
to more patients to capture their genomic, clinical and immune information.
To achieve our goal, later this year we are launching an exciting new initiative —
the MMRF CureCloud™ — a hub for multiple myeloma data. We are working with
world-class partners, such as the Broad Institute, COTA and Tempus, to generate,
aggregate and drive analytics for this rich, new data resource.
One important way that we will be building out the CureCloud is by going
directly to patients to collect their data. A pilot effort is currently underway, with
a full program launching in the fall, where patients will be able to consent online
to share information about their disease. This will help patients and their doctors
make better evidence-based treatment decisions. Ultimately, what we learn from
the CureCloud will accelerate us toward a cure for every patient.
a cce l e rat o r • Su m m e r 2 0 18
5